期刊文献+

《欧洲卒中组织(ESO)移动卒中单元院前卒中管理指南》解读

Interpretation of European Stroke Organisation(ESO)guidelines on mobile stroke units for prehospital stroke management
原文传递
导出
摘要 脑卒中已成为危害人类身体健康的重大神经系统疾病,救治的关键是解决在"1 h黄金时间"内即时诊断与治疗的"瓶颈"问题。2022年《欧洲卒中组织(ESO)移动卒中单元院前卒中管理指南》发表,这是全球第1个移动卒中单元(MSU)院前卒中管理指南。指南建议:对于确诊的急性缺血性脑卒中患者,使用MSU进行院前管理可改善其临床功能效果,提高静脉溶栓治疗率,缩短开始溶栓治疗时间。对于颅内出血患者,使用MSU进行院前管理可增加直接分配运送到三级医疗卒中中心的患者比例,而无需担心短期死亡率。对类卒中患者使用MSU管理没有发现相关安全问题。本文就该指南进行解读,以更好地指导临床实践。 Stroke has become a major nervous system disease that endangers human health.The key to cure is to solve the"bottleneck"problem of immediate diagnosis and treatment within the"1 h golden time".In 2022,the"European Stroke Organisation(ESO)guidelines on mobile stroke units for prehospital stroke management"was published,which is the first mobile stroke unit(MSU)prehospital stroke management guide in the world.Guideline recommendations:For patients with confirmed acute ischemic stroke,using MSU for prehospital management can improve their clinical function,increase the rate of IVT treatment,and shorten the time to start thrombolytic therapy.For patients with intracranial hemorrhage,using MSU for prehospital management can increase the proportion of patients directly assigned to tertiary medical stroke centers without concern about short-term mortality.No relevant safety concerns were identified with MSU management in suspected stroke patients.This article will interpret this guideline to better guide clinical practice.
作者 徐如祥 Ruxiang Xu(Department of Neurosurgery,Sichuan Academy of Medical Sciences·Sichuan Provincial People's Hospital,Chengdu 610072,China)
出处 《中华脑科疾病与康复杂志(电子版)》 2023年第1期5-33,共29页 Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition)
关键词 脑卒中 指南解读 移动卒中单元 院前救治管理 Stroke Guideline interpretation Mobile stroke unit Prehospital treatment and management
  • 相关文献

参考文献2

二级参考文献20

  • 1Davis S. M.,Broderick J.,Hennerici M.,张慧(译).脑内出血后血肿增大是死亡和预后不良的决定因素[J].世界核心医学期刊文摘(神经病学分册),2006,2(9):15-15. 被引量:23
  • 2Schunemann HJ, Cook D, Guyatt G. Methodology for antithrom- botic and thrombolytic therapy guideline development: American College of Chest Physicians Evidence-based Clinical Practice Guide- lines (8th Edition). Chest, 2008, 133(6 Suppl): 113S-122S.
  • 3CAPRIE Steering Committee, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 1997.
  • 4Letelier LM, Udol K, Ena J, et al. Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis. Arch Intern Med, 2003, 163(7): 777-785.
  • 5Guyatt G, Oxman AD, Kunz R, et al. Grade Guidelines: 6. Rating the quality of evidence: Inconsistency. Journal of Clnical Epidemiology, 2010.
  • 6Eikelboom J, Guyatt G, Hirsh J. Guidelines for anticoagulant use in acute coronary syndromes. Lancet, 2008, 371 (9624): 1559-1561.
  • 7Furukawa TA, Guyatt GH, Griffith LE. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int J Epiderniol, 2002, 31 (1): 72-76.
  • 8Schmid, CH, Lau J, Mcintosh MW, et al. An empirical study of the effect of the control rate as a predictor of treatment efficacy in metaanalysis of clinical trials. Stat Med, 1998, 17(17): 1923-1942.
  • 9Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med, 2002, 21(11): 1575-1600.
  • 10Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians EvidenceBased Clinical Practice Guidelines (8th Edition). Chest, 2008, 133(6 Suppl): 546S-592S.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部